Catalyst Wire Dossier Catalyst Wire Dossier

UCMSCs (umbilical cord mesenchymal stem cells) from allogeneic source

umbilical cord mesenchymal stem cells · Cytopeutics Sdn. Bhd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UCMSCs (umbilical cord mesenchymal stem cells) from allogeneic source, covering 2024-01-03 to 2024-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury [Phase 2]

See pricing